Page last updated: 2024-11-01

omeprazole and Anti-Phospholipid Antibody Syndrome

omeprazole has been researched along with Anti-Phospholipid Antibody Syndrome in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cicconi, V1
Carloni, E1
Franceschi, F1
Nocente, R1
Silveri, NG1
Manna, R1
Servidei, S1
Bentivoglio, AR1
Gasbarrini, A1
Gasbarrini, G1

Other Studies

1 other study available for omeprazole and Anti-Phospholipid Antibody Syndrome

ArticleYear
Disappearance of antiphospholipid antibodies syndrome after Helicobacter pylori eradication.
    The American journal of medicine, 2001, Volume: 111, Issue:2

    Topics: Adult; Antiphospholipid Syndrome; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Heli

2001